3034-6231

Medicine and Biotechnology

National Research Mordovia State University MRSU

Health Score

0 Excellent

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 5 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact5 DOIs
2

Deposit reference lists for 5 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact5 DOIs
3

Attach ORCID iDs across 2 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact2 DOIs

DOIs for this ISSN

Showing the top 5 of 47 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Scientific horizons of the journal "Medicine and Biotechnolo… (10.15507/3034-6231.001.202501.010-012)
Abstract References
0.00 0
2 Hypereosinophilic Syndrome: Contemporary Approaches to Molec… (10.15507/3034-6231.001.202501.013-023)
0.00 1
3 Challenges in the Diagnosis of Abdominal Actinomycosis (10.15507/3034-6231.001.202501.024-031)
0.00 0
4 Cardiac Arrhythmias and Conduction Disorders in Geriatric Pa… (10.15507/3034-6231.001.202501.032-040)
0.00 2
5 Epidemiological and Pathophysiological Features of Gastric… (10.15507/3034-6231.001.202501.041-050)
0.00 0
6 The Relationship between Hemostasis Disorders and Oxidative… (10.15507/3034-6231.001.202501.051-058)
0.00 0
7 Functional Parameters of the Cardiorespiratory System in In… (10.15507/3034-6231.001.202501.059-066)
0.00 0
8 Study of Neuropsychological Indicators, Saccades, and Antisa… (10.15507/3034-6231.001.202501.067-081)
0.00 0
9 Prospects of the Federal Center for Biotechnology and Medici… (10.15507/3034-6231.001.202502.098-101)
Abstract References
0.00 0
10 Production of Functional Dairy Products using Algae-based Ad… (10.15507/3034-6231.001.202502.102-118)
0.00 0
11 Challenges in the Treatment of Oncological Diseases during P… (10.15507/3034-6231.001.202502.119-129)
0.00 1
12 The use of oral immunotherapy for the treatment of food alle… (10.15507/3034-6231.001.202502.130-139)
0.00 1
13 Some Pathogenic Mechanisms of the Development of Mental Diso… (10.15507/3034-6231.001.202502.140-153)
0.00 5
14 The Impact of Polygenic Mutation Combinations on the Progres… (10.15507/3034-6231.001.202502.154-167)
0.00 0
15 The Impact of Noise Exposure on Psychophysiological Parame… (10.15507/3034-6231.001.202502.168-176)
0.00 0
16 Evaluation of the Effectiveness of Benralizumab in a Patient… (10.15507/3034-6231.001.202502.193-201)
0.00 0
17 Grant Support for Medical Scientific Projects in 2024 (10.15507/3034-6231.001.202503.202-205)
Abstract References
0.00 0
18 Contemporary Approaches to Pain Assessment Methodologies (10.15507/3034-6231.001.202503.206-223)
0.00 0
19 Intestinal Dysfunction in Acute Peritonitis (10.15507/3034-6231.001.202503.224-231)
0.00 0
20 The Efficacy of Butylphthalide in Patients with Acute Ischem… (10.15507/3034-6231.001.202503.232-241)
0.00 0
21 Analysis of Prevalence, Structure, Treatment of Chronic Kidn… (10.15507/3034-6231.001.202503.242-251)
0.00 0
22 Hepatic Sarcoidosis: A Modern View on the Issue (10.15507/3034-6231.001.202503.252-268)
0.00 1
23 Kidney Involvement in Spondyloarthritis: A Literature Review (10.15507/3034-6231.001.202503.269-285)
0.00 0
24 Analysis of Methods for Normalizing Lipid Profile and Blood… (10.15507/3034-6231.001.202503.286-297)
0.00 0
25 Prospects for the Development of Intelligent Mechanical Vent… (10.15507/3034-6231.001.202503.298-306)
0.00 0
26 The Restoration of Mental Function Following Severe Stress:… (10.15507/3034-6231.001.202504.322-341)
0.00 0
27 Resveratrol in the Therapy and Prevention of Parkinson’s Dis… (10.15507/3034-6231.001.202504.342-355)
0.00 0
28 Analysis of the Current State and Trends in the Field of Pha… (10.15507/3034-6231.001.202504.356-375)
0.00 0
29 Formation of Interspecies Biofilms of Saccharomyces cerevisi… (10.15507/3034-6231.001.202504.376-382)
0.00 0
30 Nutritional Status and its Association with Physical Develop… (10.15507/3034-6231.001.202504.383-395)
0.00 0
31 Clinical Case Report of Cavernous Sinus Thrombosis with an A… (10.15507/3034-6231.001.202504.396-401)
0.00 0
32 Clinical Evaluation of an Immunological Method for Predictin… (10.15507/3034-6231.001.202504.402-408)
0.00 0
33 Optimization of Calcium Phosphate Transfection Protocol (10.15507/3034-6231.002.202601.010-021)
0.00 0
34 Beta-Blockers no Longer Needed Post Myocardial Infarction in… (10.15507/3034-6231.002.202601.022-036)
0.00 0
35 Gas Chromatography: Historical Milestones of Development, Di… (10.15507/3034-6231.002.202601.037-046)
0.00 0
36 Assessment of Heart Rate and Cardiac Repolarization Paramete… (10.15507/3034-6231.002.202601.047-057)
0.00 0
37 Effects of Hypoglycemic and Hypolipidemic Drugs on Intestina… (10.15507/3034-6231.002.202601.058-070)
0.00 0
38 Evaluation of the Effect of Tumor Localization, Stage, Sex a… (10.15507/3034-6231.002.202601.071-087)
0.00 0
39 Preliminary Technical and Technological Solutions for Mainta… (10.15507/3034-6231.002.202601.088-096)
0.00 0
40 The Impact of Residual Antibacterial Agents in Quail Embryos… (10.15507/3034-6231.26022.114-123)
0.00 0
41 Conservative Treatment of Lumbosacral Intervertebral Disc He… (10.15507/3034-6231.26022.124-133)
0.00 0
42 The Role of Immune Mechanisms and Gastroduodenal Microbiota… (10.15507/3034-6231.26022.134-149)
0.00 0
43 Heart Rate Variability as a Marker of Autonomic Imbalance in… (10.15507/3034-6231.26022.150-164)
0.00 0
44 The Influence of Organic Fermented Milk Products on Some Ind… (10.15507/3034-6231.26022.165-178)
0.00 0
45 Impact of Combined Therapy on the Dynamics of Psychopatholog… (10.15507/3034-6231.26022.179-193)
0.00 0
46 Diabetogenic Potential of Statins: Mechanisms, Risk Factors,… (10.15507/3034-6231.26022.194-204)
0.00 0
47 CrossMark Policy (10.15507/3034-6231/crossmark)
Abstract References ORCID License
0.00 0